This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Eugene D. Shapiro, MD; Trudy V. Murphy, MD; Ellen R. Wald, MD; Christine A. Brady, MPhil

JAMA. 1988;260(10):1419-1422.

Abstract
To assess the protective efficacy of the Haemophilus b polysaccharide vaccine, a case-control study was conducted in Connecticut, Dallas County, and greater Pittsburgh. Seventy-six children 24 to 72 months of age who had H influenzae type b isolated from normally sterile sites from August 1985 through July 1987 were enrolled. For each case two controls, matched by age and place of residence, were randomly selected from the records of all live births in the area. Antecedent receipt of the Haemophilus b polysaccharide vaccine was ascertained from the records of all physicians and clinics at which the subjects received medical care. Overall, 12% of the cases and 39% of the controls had received the vaccine. The estimate of the protective efficacy of the vaccine was 88% overall (95% confidence interval, 74% to 96%) and 91% (95% confidence interval, 71% to 99%), 92% (95% confidence interval, 76% to 99%), and 81% (95% confidence interval, 45% to 96%) in Connecticut, Dallas County, and greater Pittsburgh, respectively. The estimates were not substantially affected by adjusting with logistic regression for differences between the cases and controls in race and the attendance of group day care. We conclude that the Haemophilus b polysaccharide vaccine is highly effective in these areas among children who receive the vaccine when they are 24 months of age or older.

(JAMA 1988;260:1419-1422)

Author Affiliations
From the Departments of Pediatrics (Dr Shapiro) and Epidemiology (Dr Shapiro and Ms Brady), Yale University School of Medicine, New Haven, Conn; the Department of Pediatrics, University of Texas Southwestern School of Medicine, Dallas (Dr Murphy); and the Department of Pediatrics, University of Pittsburgh School of Medicine (Dr Wald).

Footnotes
Reprint requests to Department of Pediatrics, Yale School of Medicine, PO Box 3333, New Haven, CT 06510-8064 (Dr Shapiro).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Worldwide Haemophilus influenzae Type b Disease at the Beginning of the 21st Century: Global Analysis of the Disease Burden 25 Years after the Use of the Polysaccharide Vaccine and a Decade after the Advent of Conjugates
Peltola
Clin. Microbiol. Rev. 2000;13:302-317.
ABSTRACT | FULL TEXT  

Eradication of Haemophilus influenzae Type b Disease in Southern California
Vadheim et al.
Arch Pediatr Adolesc Med 1994;148:51-56.
ABSTRACT  

Declining Incidence of Haemophilus influenzae Type b Disease Since Introduction of Vaccination
Murphy et al.
JAMA 1993;269:246-248.
ABSTRACT  

Haemophilus b Disease After Vaccination With Haemophilus b Polysaccharide or Conjugate Vaccine
Frasch et al.
Arch Pediatr Adolesc Med 1991;145:1379-1382.
ABSTRACT  

Immunoglobulin Deficiency and Idiotype Expression in Children Developing Haemophilus influenzae Type b Disease After Vaccination With Conjugate Vaccine
Holmes et al.
JAMA 1991;266:1960-1965.
ABSTRACT  

Dose-Related Immunogenicity of Haemophilus influenzae Type b Capsular Polysaccharide--Neisseria meningitidis Outer Membrane Protein Conjugate Vaccine
Wong et al.
Arch Pediatr Adolesc Med 1991;145:734-741.
ABSTRACT  

Protective Efficacy of Haemophilus influenzae Type b Polysaccharide and Conjugate Vaccines in Children 18 Months of Age and Older
Greenberg et al.
JAMA 1991;265:987-992.
ABSTRACT  

Protective Efficacy of Haemophilus influenzae Type b Polysaccharide-Diphtheria Toxoid-Conjugate Vaccine
Nelson and Granoff
Arch Pediatr Adolesc Med 1990;144:292-295.
ABSTRACT  

Interannual Variation of the Incidence of Haemophilus influenzae Type b Meningitis
Sherry et al.
JAMA 1989;261:1924-1929.
ABSTRACT  

Haemophilus b Polysaccharide Vaccine
Coles et al.
JAMA 1989;261:1152-1152.
ABSTRACT  

Haemophilus b Polysaccharide Vaccine-Reply
Harrison and Broome
JAMA 1989;261:1153-1153.
ABSTRACT  

CONFLICTING DATA ON EFFICACY OF HAEMOPHILUS B VACCINE
JWatch General 1988;1988:1-1.
FULL TEXT  

Lack of Efficacy of Haemophilus b Polysaccharide Vaccine in Minnesota
Osterholm et al.
JAMA 1988;260:1423-1428.
ABSTRACT  

Efficacy of Haemophilus b Polysaccharide Vaccine: An Enigma
Mortimer
JAMA 1988;260:1454-1455.
ABSTRACT